Coherus Oncology, Inc. (CHRS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 5M 10M 15M Q3 '24: 6.1M Q4 '24: 7.7M Q1 '25: 7.6M Q2 '25: 10.3M Q3 '25: 11.6M Q4 '25: 12.7M Q1 '26: 12.3M Q2 '26: 14.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 40M 80M 120M Q1 '19: 34.9M Q2 '19: 82.8M Q3 '19: 105.2M Q4 '19: 116.1M Q1 '19 Q2 '19 Q3 '19 Q4 '19

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '24: -46.9M Q4 '24: -45.4M Q1 '25: -45.4M Q2 '25: -45.5M Q3 '25: -44.3M Q4 '25: -45.9M Q1 '26: -36.2M Q2 '26: -32.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-150M 0 150M 300M 450M Q3 '24: -10.8M Q4 '24: -50.7M Q1 '25: -56.6M Q2 '25: 297.8M Q3 '25: -35.5M Q4 '25: -37.6M Q1 '26: -38.3M Q2 '26: -20.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q3 '24: 2.7M Q4 '24: 2.8M Q1 '25: 2.7M Q2 '25: 3.4M Q3 '25: 3.7M Q4 '25: 4M Q1 '26: 3.8M Q2 '26: 4.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '24: -62M Q4 '24: 28.6M Q1 '25: -25.8M Q2 '25: -46.6M Q3 '25: -46.3M Q4 '25: -19.7M Q1 '26: -57.9M Q2 '26: -62.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-105M -70M -35M 0 35M 70M 105M Q1 '22: -54.7M Q2 '22: -50.9M Q3 '22: -37.5M Q4 '22: -100M Q1 '23: -68.9M Q2 '23: -39M Q3 '23: -54.3M Q4 '23: -13M Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '24: 112.7M Q2 '24: 114.8M Q3 '24: 115.2M Q1 '25: 116.1M Q2 '25: 116.1M Q3 '25: 116.2M Q1 '26: 136.4M Q2 '26: 154.8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '23: -3.32 Q3 '23: -2.62 Q4 '23: -2.60 Q1 '24: -0.73 Q2 '24: -0.35 Q3 '24: -0.03 Q1 '26: -1.42 Q2 '26: -4.12 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.